Summary
Unlocking the Secret: The Impact of Testosterone on Women’s Health explores the vital yet often underappreciated role of testosterone in female physiology and well-being. While commonly known as the primary male sex hormone, testosterone is also produced in women by the ovaries, adrenal glands, and peripheral tissues, where it influences a broad spectrum of functions beyond reproduction. These include maintaining bone density, muscle mass, cognitive health, mood regulation, sexual desire, cardiovascular function, and red blood cell production, highlighting its significance across the female lifespan.
Testosterone levels in women vary with age, peaking in early adulthood and gradually declining after menopause, which can contribute to symptoms such as reduced libido, fatigue, mood changes, and loss of muscle strength. Both low and high testosterone levels are associated with clinical conditions; deficiency may lead to hypogonadism and decreased quality of life, while excess testosterone—often seen in disorders like polycystic ovary syndrome (PCOS)—can cause symptoms such as hirsutism, acne, and menstrual irregularities. Accurate diagnosis and interpretation of testosterone levels in women remain challenging due to biological variability and overlapping symptoms with other hormonal imbalances.
Therapeutic use of testosterone in women, particularly for hypoactive sexual desire disorder (HSDD), has shown promise in improving sexual function and quality of life, though its application remains controversial. Currently, no testosterone formulations are FDA-approved specifically for women in the United States, leading to off-label use of male preparations or compounded formulations, which raises concerns regarding safety, dosing consistency, and long-term effects. Medical societies generally recommend cautious, individualized use of testosterone therapy, emphasizing the need for further research to clarify benefits, risks, and guidelines.
Recent advances in assay technologies and growing clinical awareness have deepened understanding of testosterone’s multifaceted role in women’s health, fostering a more nuanced approach to diagnosis and management. Continued research is essential to unlock the full therapeutic potential of testosterone while addressing controversies related to safety, regulatory approval, and optimal treatment strategies across different life stages.
Overview of Testosterone
Testosterone is a sex hormone primarily recognized for its role in male physiology, where it acts as the primary male sex hormone and androgen. It is crucial in the development of male reproductive tissues, such as the testicles and prostate, and in promoting secondary sexual characteristics including increased muscle and bone mass, body hair growth, and libido. Although often associated with males, testosterone is also produced in smaller amounts in females, primarily by the ovaries and adrenal glands.
In males, testosterone biosynthesis occurs almost exclusively in mature Leydig cells within the testes. The process begins with cholesterol, predominantly synthesized de novo from acetyl-CoA, which is converted into pregnenolone in mitochondria under the regulation of luteinizing hormone (LH). This hormone production is part of the hypothalamic–pituitary–gonadal (HPG) axis, where gonadotropin-releasing hormone (GnRH) from the hypothalamus stimulates the pituitary gland to release LH and follicle-stimulating hormone (FSH), which in turn regulate testosterone production and spermatogenesis.
Testosterone production in females is less well understood but is similarly regulated by the HPG axis. About one quarter of female testosterone is produced in the ovaries, another quarter in the adrenal glands, and approximately half is generated in peripheral tissues through the conversion of androgen precursors such as dehydroepiandrosterone (DHEA) and androstenedione. Much of the ovarian testosterone is aromatized into estradiol, the major estrogenic steroid in females.
Beyond its reproductive roles, testosterone serves as a signaling molecule that sends chemical messages throughout the body, influencing both reproductive and non-reproductive tissues in men and women. In males, testosterone is converted at the cellular level into dihydrotestosterone (DHT) by the enzyme 5α-reductase, which is vital for the development of male external genitalia and secondary sexual characteristics. In addition, testosterone exerts retrocontrol effects on Leydig cells and participates in complex regulatory feedback loops involving multiple physiological factors and enzymes.
Testosterone levels in both sexes exhibit diurnal variation, typically peaking in the morning and declining throughout the day. Abnormal testosterone levels in women can be indicative of underlying conditions such as tumors of the ovaries or adrenal glands and may require clinical management to restore hormonal balance. Furthermore, changes in testosterone production, especially after menopause, may contribute to various symptoms linked to androgen deficiency due to decreased synthesis by the ovaries and adrenal glands.
Testosterone Levels in Women
Testosterone, often perceived as a “male hormone,” plays a vital role in women’s health, with normal levels typically ranging between 9 and 55 ng/dL in women, compared to much higher levels in men, which generally range from 240 to 950 ng/dL. In women, testosterone is produced primarily in the ovaries and adrenal glands and is crucial for various physiological functions, including maintaining muscle mass, bone density, cognitive function, mood regulation, and sexual desire.
Age-Related Variations
Testosterone levels in women fluctuate throughout life and are influenced by age and hormonal status. Levels are generally low in childhood (below 25 ng/dL) and increase during puberty, which typically begins between ages 8 and 13 in females. Testosterone peaks during late adolescence and early adulthood and gradually declines with age, particularly after menopause, which usually occurs between 45 and 55 years of age. Postmenopausal women often experience a significant decrease in testosterone production, contributing to symptoms such as reduced libido, decreased muscle strength, and changes in mood.
Clinical Measurement and Interpretation
Accurate measurement of testosterone in women requires careful timing, usually in the morning between 8 AM and 10 AM, to account for biological variability. Interpreting these levels demands expertise because normal ranges can vary significantly across laboratories and among individuals, influenced by factors such as age, menstrual cycle phase, and overall health status. Importantly, having testosterone levels within the normal range does not necessarily exclude hormone-related symptoms, making clinical context essential for diagnosis and treatment planning.
Implications of Low Testosterone
Low testosterone in women can manifest as loss of sexual desire, fatigue, mood disturbances, and diminished muscle mass. It is a key consideration in women experiencing hypogonadism or other hormonal imbalances. Testosterone replacement therapy is sometimes prescribed primarily to address loss of sexual desire, but its use requires caution, especially in women who are pregnant, breastfeeding, or have hormone-sensitive conditions.
Lifestyle and Management
In addition to medical interventions, lifestyle changes can help manage abnormal testosterone levels. Maintaining a healthy weight and balanced diet can improve symptoms, particularly in conditions like polycystic ovary syndrome (PCOS) that involve elevated testosterone. Managing hirsutism and acne through hair removal and skincare is also common in women with excess testosterone.
Physiological Roles of Testosterone in Women
Testosterone, often regarded as the quintessential male hormone, plays several crucial and diverse roles in the female body. Although present in lower concentrations compared to men, testosterone in women is primarily produced by the ovaries, adrenal glands, and peripheral tissues, and it exerts significant effects on multiple physiological systems.
Bone Health and Musculoskeletal Maintenance
One of the key functions of testosterone in women is the maintenance of bone health. It supports bone growth and strength by promoting bone mineral density (BMD), helping to prevent osteoporosis and fractures, especially in aging women. Testosterone acts directly through androgen receptors on osteoblasts and osteocytes and indirectly via its conversion to estrogen, which also influences skeletal integrity. Studies indicate that lower free testosterone levels in women during their late reproductive years correlate with a significant decline in BMD. Additionally, testosterone contributes to the preservation and development of muscle mass, which is essential for overall physical strength and metabolic health.
Sexual Function and Libido
Testosterone plays a vital role in regulating female sexual desire and function. Low testosterone levels have been linked to reduced libido, which can negatively affect quality of life and intimate relationships. Increasing testosterone within physiological ranges may improve sexual desire and pleasure in women experiencing hypoactive sexual desire disorder, though low libido is often multifactorial and influenced by mood, sleep, hormonal changes, and psychosocial factors.
Mood, Cognition, and Neuroprotection
Beyond its physical effects, testosterone influences mood regulation, energy levels, and cognitive function in women. It acts as a neuroactive hormone by modulating neurotransmitter systems such as dopamine and serotonin, which affect mood and cognitive processes including attention, memory, and spatial ability. Evidence suggests that testosterone has neuroprotective and anti-inflammatory actions within the female brain, potentially playing a role in reducing cognitive decline and dementia risk. Furthermore, testosterone has been associated with prosocial behavior and neural plasticity by promoting synaptogenesis and neurite development.
Cardiovascular and Metabolic Effects
Testosterone contributes to cardiovascular health in women by exerting favorable effects on vasomotor tone and endothelial function at physiological concentrations. Contrary to the common belief that testosterone may increase cardiovascular risk, a hypoandrogenic state in women has been found to be detrimental to cardiovascular function. Additionally, testosterone supports metabolic functions, including energy production and the regulation of fat distribution, which become particularly important as women age.
Hematopoiesis and Red Blood Cell Production
Testosterone enhances erythropoiesis, the process of red blood cell formation, which partially explains sex differences in hemoglobin and hematocrit levels. In women, declining testosterone levels with age may contribute to reduced red blood cell production and a higher risk of anemia.
Role in the Hypothalamic–Pituitary–Gonadal Axis
Testosterone levels in women are tightly regulated by the hypothalamic–pituitary–gonadal (HPG) axis, a complex endocrine system involving the hypothalamus, pituitary gland, and gonads. This axis orchestrates reproductive function and hormone balance, influencing puberty, fertility, and overall endocrine health. Testosterone also modulates the secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH), hormones that regulate ovarian function.
Clinical Conditions Associated with Testosterone Imbalance
Testosterone plays a critical role in maintaining various physiological functions in women, and imbalances—either excess or deficiency—can lead to several clinical conditions with diverse symptoms and health implications.
Low Testosterone in Women
Low testosterone levels in women can manifest through a range of symptoms including vaginal dryness, hot flashes, night sweats, fatigue, muscle weakness, thinning hair, weight gain, irregular menstrual cycles, dry skin, mood disturbances, difficulty concentrating, and decreased libido. These symptoms often overlap with those caused by low estrogen, making diagnosis challenging. Low testosterone may also affect energy production, cognitive function, bone density, and cardiovascular health, thereby compromising overall well-being.
Diagnosis typically involves a healthcare provider assessing symptoms, conducting a physical exam, and ordering blood tests to measure hormone levels, often performed in the morning when testosterone is highest. Treatment options, such as hormone replacement therapy (HRT), exist but are not universally approved and carry potential risks; therefore, medical guidance and careful consideration are essential before initiating therapy.
High Testosterone and Hyperandrogenism
Excess testosterone, or hyperandrogenism, affects approximately 5% to 10% of women of reproductive age and can produce symptoms such as hirsutism (excessive hair growth on the face, back, and chest), acne, scalp hair thinning, and in severe cases, virilization characterized by deepening of the voice, clitoral enlargement, and increased muscle mass. Causes of elevated testosterone may include polycystic ovary syndrome (PCOS), adrenal or ovarian tumors, congenital adrenal hyperplasia (CAH), and certain metabolic syndromes.
PCOS is a common endocrine disorder characterized by excess androgen production from the ovaries, leading to menstrual irregularities and infertility. Adrenal tumors and CAH result from abnormalities in steroidogenesis within the adrenal cortex, contributing to androgen excess. Diagnosis generally requires a combination of clinical evaluation, hormonal blood tests, and imaging studies such as pelvic ultrasound to detect ovarian abnormalities.
Other Related Conditions
Testosterone imbalance may also be associated with broader endocrine disorders and systemic health issues. For example, low testosterone can coincide with hypothalamic or pituitary axis dysfunction, certain genetic syndromes, or effects from chemotherapy and medications. Conversely, high testosterone levels may increase risks for cardiovascular disease and metabolic disturbances, necessitating comprehensive management and monitoring.
Given the complexity of testosterone’s effects and the variability of symptoms, healthcare providers emphasize individualized evaluation and treatment. Monitoring hormone levels and symptom progression is critical for managing both low and high testosterone conditions safely and effectively.
Testosterone Therapy in Women
Testosterone therapy in women is primarily considered for the treatment of hypoactive sexual desire disorder (HSDD), a condition characterized by distressing low sexual desire affecting approximately 10% of adult women. Testosterone plays an essential physiological role in women, influencing libido, bone density, muscle strength, mood, and energy levels. Despite its importance, the use of testosterone therapy in women remains controversial and less studied compared to men.
Indications and Efficacy
The main clinical indication for testosterone therapy in women is to address low libido, particularly when diagnosed as HSDD. Randomized placebo-controlled trials have demonstrated that testosterone therapy can improve sexual function and desire in some women experiencing sexual dysfunction. Testosterone’s positive effects on sexual health are linked to its physiological actions either directly or via conversion to estradiol. However, low libido is multifactorial, with contributing factors including sleep disturbances, mood disorders, genitourinary syndrome of menopause, stress, and relationship issues. Therefore, testosterone therapy is not universally effective and should be considered within a comprehensive clinical assessment.
Beyond sexual function, emerging research is investigating the broader benefits of testosterone supplementation in women. These include potential improvements in bone mineral density, muscle mass, anemia, cognitive function, and overall quality of life. Some studies have suggested that testosterone therapy may offer protective effects against breast cancer, contrary to early concerns of increased risk, although regulatory approval for such indications remains lacking.
Forms of Testosterone Therapy
Currently, no testosterone formulations are FDA-approved specifically for women in the United States. Consequently, clinicians often prescribe testosterone off-label by adapting existing male formulations or utilizing compounded low-dose gels, creams, patches, pellets, or injections tailored for women. Compounded formulations, however, lack standardized regulation, raising concerns about dosing accuracy and product quality. Pellet therapy is less common and remains controversial due to limited evidence and potential risks.
Safety and Monitoring
Testosterone therapy is contraindicated in pregnant or breastfeeding women, those with active liver disease, hormone-sensitive cancers, uncontrolled hyperlipidemia, or severe acne. Women considering therapy should undergo thorough evaluation and discuss potential risks and benefits with their healthcare provider. Since testosterone affects multiple organ systems, ongoing monitoring of hormone levels, symptom improvement, and side effects is essential during treatment.
Adverse effects of testosterone therapy can include virilization symptoms such as clitoral enlargement and increased body hair, although these are more common with prolonged high-dose exposure. Careful dose titration and lifestyle modifications, including strength training, stress management, sleep optimization, and nutrition, can complement hormonal treatment and support endogenous testosterone levels.
Controversies and Future Directions
The lack of FDA-approved testosterone therapies for women reflects the current gaps in clinical research and regulatory consensus. Many professional societies recommend against routine testosterone treatment in women unless specific criteria are met due to limited long-term safety data and variability in individual responses. Ongoing studies aim to clarify testosterone’s role beyond sexual health, including its
Age-Related Changes and Life Stage Considerations
Testosterone levels in women fluctuate throughout different stages of life, influencing various aspects of health and well-being. During puberty, testosterone contributes to physical development and libido in both sexes, although it is present in much greater levels in men than in women. In females, testosterone plays a role in muscle and bone strength as well as sexual function.
As women approach perimenopause and menopause, typically between the ages of 45 and 55, hormonal changes become more pronounced. Estrone, the main estrogen present during and after menopause, begins to dominate as overall estrogen levels decline, which can contribute to symptoms such as increased risk of heart disease and osteoporosis. Concurrently, testosterone levels tend to decrease after menopause, although some studies indicate that in women over 70 years of age, testosterone levels may rise again to levels comparable to those seen in premenopausal women. This resurgence may have implications for maintaining health in older age.
Given these fluctuations, comprehensive hormone testing—including measuring testosterone and estrone levels—is essential for understanding individual hormonal baselines and guiding personalized treatment strategies during midlife and beyond. Moreover, sex hormone-binding globulin (SHBG), which binds testosterone and affects its bioavailability, has been observed to increase with age, further influencing the hormonal milieu in aging women.
Understanding these age-related hormonal dynamics is crucial for addressing symptoms related to energy, mood, muscle mass, and sexual function in women as they age. Effective management of these changes can contribute to reducing years lived with disability and improving overall quality of life in older women.
Diagnostic Methods and Clinical Evaluation
The clinical evaluation of testosterone-related conditions in women typically begins with a thorough physical examination and detailed medical history. Healthcare providers look for physical signs such as excessive body hair growth, which may indicate hyperandrogenism, and inquire about symptoms related to menstrual cycles, libido, and mood changes to assess overall hormonal health.
When conditions like polycystic ovary syndrome (PCOS) are suspected, a pelvic ultrasound may be performed to detect any ovarian abnormalities. If elevated testosterone levels are suspected based on clinical features, blood tests are ordered to measure hormone concentrations, particularly total testosterone, which quantifies the overall amount of testosterone circulating in the bloodstream.
Laboratory testing is ideally conducted in the morning between 8 AM and 10 AM to account for diurnal variations in testosterone levels. Due to biological variability, a repeat morning measurement may be required to confirm initial findings. Advanced and highly sensitive assay techniques, such as liquid chromatography followed by tandem mass spectrometry (LC-MS/MS), are preferred over direct immunoassays to ensure accuracy in testosterone measurement. If free testosterone levels are needed, they are typically calculated based on accurately measured total testosterone using validated methods.
Understanding the regulation of testosterone within the hypothalamic–pituitary–gonadal (HPG) axis is essential, as this endocrine system governs the production and balance of sex hormones in women, influencing reproductive and immune system functions. Accurate diagnosis through clinical evaluation and hormone measurement is crucial to guide appropriate management of conditions associated with abnormal testosterone levels in women.
Recent Research and Advances
Recent research has increasingly highlighted the critical role of testosterone in women’s health, emphasizing its multifaceted impact on physiological and psychological well-being. Although traditionally considered a “male hormone,” testosterone is now recognized as essential for various functions in women, including bone density maintenance, libido regulation, muscle mass preservation, and mood stabilization. Modern assay techniques, such as liquid or gas chromatography coupled with tandem mass spectrometry, have improved the accuracy of measuring total testosterone levels, surpassing older methods like radioimmunoassay.
Studies underscore that testosterone is primarily produced in the ovaries, adrenal glands, and peripheral tissues in women, and its influence extends beyond reproductive health. Age-related hormonal changes, especially during perimenopause and menopause, have drawn attention to the need for comprehensive hormone testing, including testosterone assessments, to tailor personalized treatment strategies. Such approaches aim to monitor baseline hormone levels and track variations to optimize therapeutic outcomes.
Therapeutic advances include bioidentical hormone therapy and supplementation with precursors such as dehydroepiandrosterone (DHEA), which can enhance endogenous testosterone synthesis. However, experts caution that testosterone therapy in women should be approached judiciously and only under professional supervision due to potential risks and the lack of standardized treatment criteria. Many respected medical societies recommend against indiscriminate use of testosterone treatments unless specific clinical indications are met.
Collectively, these advances in understanding testosterone’s role and improving diagnostic and treatment modalities signify a shift toward more nuanced management of female hormonal health, with ongoing research continuing to elucidate optimal therapeutic frameworks.
The content is provided by Jordan Fields, ZenModeLife
